Abstract
A patient who suffered from severe decrease of accommodation and pupillary dilatation following the systemic use of disopyramide is described. The ocular side effects when this drug is used in large doses result from its anticholinergic action.
Full text
PDF

Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Danilo P., Jr, Rosen M. R. Cardiac effects of disopyramide. Am Heart J. 1976 Oct;92(4):532–536. doi: 10.1016/s0002-8703(76)80054-3. [DOI] [PubMed] [Google Scholar]
- Koch-Weser J. Disopyramide. N Engl J Med. 1979 Apr 26;300(17):957–962. doi: 10.1056/NEJM197904263001705. [DOI] [PubMed] [Google Scholar]
- RIKER W. F., Jr Contributions to medicine by research in pharmacology. Some aspects of dosage. JAMA. 1962 Feb 3;179:355–360. doi: 10.1001/jama.1962.03050050045008. [DOI] [PubMed] [Google Scholar]
- Singh B. N., Collett J. T., Chew C. Y. New perspectives in the pharmacologic therapy of cardiac arrhythmias. Prog Cardiovasc Dis. 1980 Jan-Feb;22(4):243–301. doi: 10.1016/0033-0620(80)90011-0. [DOI] [PubMed] [Google Scholar]
- Trope G. E., Hind V. M. Closed-angle glaucoma in patient on disopyramide. Lancet. 1978 Feb 11;1(8059):329–329. doi: 10.1016/s0140-6736(78)90102-2. [DOI] [PubMed] [Google Scholar]
